[S-8] ICU Medical Inc Employee Benefit Plan Registration
ICU Medical registered 2,150,000 shares of its common stock for issuance under the Third Amendment to its Amended and Restated 2011 Stock Incentive Plan, approved by stockholders at the 2025 annual meeting on May 13, 2025. The filing confirms these additional shares are the same class as prior awards and incorporates earlier Form S-8 and 10-K registrations by reference, and includes related exhibits and legal opinions.
ICU Medical ha registrato 2.150.000 azioni ordinarie da emettere ai sensi della Terza Emendamento al suo Piano di Incentivazione Azionaria del 2011 modificato e riformulato, approvato dagli azionisti nell'assemblea annuale del 13 maggio 2025. Il deposito conferma che queste azioni aggiuntive appartengono alla stessa categoria delle precedenti assegnazioni, incorpora per riferimento le precedenti registrazioni sui moduli S-8 e 10-K e include gli allegati e i pareri legali correlati.
ICU Medical registró 2.150.000 acciones ordinarias para su emisión en virtud de la Tercera Enmienda a su Plan de Incentivos en Acciones de 2011, enmendado y reformulado, aprobado por los accionistas en la junta anual del 13 de mayo de 2025. La presentación confirma que estas acciones adicionales son de la misma clase que las adjudicaciones anteriores, incorpora por referencia las inscripciones previas en los formularios S-8 y 10-K e incluye los anexos y dictámenes legales relacionados.
ICU Medical는 2025년 5월 13일 열린 연례 주주총회에서 승인된 수정·재작성된 2011년 주식 인센티브 플랜의 제3차 개정안에 따라 발행하기 위해 2,150,000주의 보통주를 등록했습니다. 이번 제출 서류는 이 추가 주식들이 이전 수여분과 동일한 종류임을 확인하고, 이전의 Form S-8 및 10-K 등록을 참조로 포함하며 관련 전시자료와 법률 의견서를 포함합니다.
ICU Medical a enregistré 2 150 000 actions ordinaires en vue de leur émission au titre du troisième amendement de son plan d'incitation en actions de 2011 modifié et refondu, approuvé par les actionnaires lors de l'assemblée générale annuelle du 13 mai 2025. Le dépôt confirme que ces actions supplémentaires sont de la même catégorie que les attributions antérieures, intègre par renvoi les enregistrements antérieurs sur les formulaires S-8 et 10-K et comprend les annexes et avis juridiques correspondants.
ICU Medical hat 2.150.000 Aktien seiner Stammaktien zur Ausgabe im Rahmen des dritten Nachtrags zu seinem geänderten und neu gefassten Aktienanreizplan von 2011 registriert, der von den Aktionären auf der Hauptversammlung am 13. Mai 2025 genehmigt wurde. Die Einreichung bestätigt, dass diese zusätzlichen Aktien derselben Klasse wie frühere Zuteilungen angehören, nimmt frühere Registrierungen in den Formularen S-8 und 10-K durch Verweisung auf und enthält zugehörige Anlagen und Rechtsgutachten.
- 2,150,000 additional shares have been registered for issuance under the company's 2011 Stock Incentive Plan
- Stockholder approval of the Third Amendment was obtained at the 2025 annual meeting
- Registration incorporates prior S-8 and 10-K filings, enabling issuance without a new standalone registration
- Filing includes legal opinion and auditor consent exhibits to support the registration
- Authorization to issue additional shares could increase the company’s outstanding share count if awards are granted
- Form S-8 provides no financial results or impact analysis; it only registers shares for plan awards
Insights
TL;DR: Routine equity refresh: 2.15M shares added to the employee plan to support awards and retention.
The Third Amendment increases the pool available under the Amended and Restated 2011 Stock Incentive Plan by 2,150,000 shares. This is a common corporate action to fund future restricted stock and performance awards for employees and executives. The registration via Form S-8 and incorporation by reference to prior filings ensures these shares are cleared for issuance without a separate registration, streamlining grant processes.
TL;DR: Stockholder-approved amendment shows governance process followed; filing documents and consents are included.
The amendment was approved by stockholders at the company's 2025 annual meeting, indicating shareholder consent for the increased award capacity. The registration statement attaches legal opinion and auditor consent exhibits, and incorporates prior S-8 and 10-K filings by reference, reflecting standard disclosure practice for employee benefit plan registrations.
ICU Medical ha registrato 2.150.000 azioni ordinarie da emettere ai sensi della Terza Emendamento al suo Piano di Incentivazione Azionaria del 2011 modificato e riformulato, approvato dagli azionisti nell'assemblea annuale del 13 maggio 2025. Il deposito conferma che queste azioni aggiuntive appartengono alla stessa categoria delle precedenti assegnazioni, incorpora per riferimento le precedenti registrazioni sui moduli S-8 e 10-K e include gli allegati e i pareri legali correlati.
ICU Medical registró 2.150.000 acciones ordinarias para su emisión en virtud de la Tercera Enmienda a su Plan de Incentivos en Acciones de 2011, enmendado y reformulado, aprobado por los accionistas en la junta anual del 13 de mayo de 2025. La presentación confirma que estas acciones adicionales son de la misma clase que las adjudicaciones anteriores, incorpora por referencia las inscripciones previas en los formularios S-8 y 10-K e incluye los anexos y dictámenes legales relacionados.
ICU Medical는 2025년 5월 13일 열린 연례 주주총회에서 승인된 수정·재작성된 2011년 주식 인센티브 플랜의 제3차 개정안에 따라 발행하기 위해 2,150,000주의 보통주를 등록했습니다. 이번 제출 서류는 이 추가 주식들이 이전 수여분과 동일한 종류임을 확인하고, 이전의 Form S-8 및 10-K 등록을 참조로 포함하며 관련 전시자료와 법률 의견서를 포함합니다.
ICU Medical a enregistré 2 150 000 actions ordinaires en vue de leur émission au titre du troisième amendement de son plan d'incitation en actions de 2011 modifié et refondu, approuvé par les actionnaires lors de l'assemblée générale annuelle du 13 mai 2025. Le dépôt confirme que ces actions supplémentaires sont de la même catégorie que les attributions antérieures, intègre par renvoi les enregistrements antérieurs sur les formulaires S-8 et 10-K et comprend les annexes et avis juridiques correspondants.
ICU Medical hat 2.150.000 Aktien seiner Stammaktien zur Ausgabe im Rahmen des dritten Nachtrags zu seinem geänderten und neu gefassten Aktienanreizplan von 2011 registriert, der von den Aktionären auf der Hauptversammlung am 13. Mai 2025 genehmigt wurde. Die Einreichung bestätigt, dass diese zusätzlichen Aktien derselben Klasse wie frühere Zuteilungen angehören, nimmt frühere Registrierungen in den Formularen S-8 und 10-K durch Verweisung auf und enthält zugehörige Anlagen und Rechtsgutachten.